Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 612

1.

Axon reflex-mediated vasodilation is reduced in proportion to disease severity in TTR-FAP.

Calero-Romero I, Suter MR, Waeber B, Feihl F, Kuntzer T.

Neurol Genet. 2018 Aug 2;4(4):e251. doi: 10.1212/NXG.0000000000000251. eCollection 2018 Aug.

2.

Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurement.

Halfon M, Wuerzner G, Marques-Vidal P, Taffe P, Vaucher J, Waeber B, Liaudet L, Ltaief Z, Popov M, Waeber G.

Blood Press. 2018 Feb;27(1):48-55. doi: 10.1080/08037051.2017.1383852. Epub 2017 Sep 28.

PMID:
28958152
3.

Triple-combination therapy in the treatment of hypertension: a review of the evidence.

Düsing R, Waeber B, Destro M, Santos Maia C, Brunel P.

J Hum Hypertens. 2017 Aug;31(8):501-510. doi: 10.1038/jhh.2017.5. Epub 2017 Feb 23. Review.

PMID:
28230062
4.

Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1.

Rignault-Clerc S, Bielmann C, Liaudet L, Waeber B, Feihl F, Rosenblatt-Velin N.

Sci Rep. 2017 Feb 9;7:41936. doi: 10.1038/srep41936.

5.

Global cardiovascular protection in chronic kidney disease.

Ruiz-Hurtado G, Sarafidis P, Fernández-Alfonso MS, Waeber B, Ruilope LM.

Nat Rev Cardiol. 2016 Oct;13(10):603-8. doi: 10.1038/nrcardio.2016.48. Epub 2016 Apr 7. Review.

PMID:
27053454
6.

[Masked hypertension. Where to look?].

Waeber B.

Praxis (Bern 1994). 2016 Mar 30;105(7):411-2. doi: 10.1024/1661-8157/a002314. French. No abstract available.

PMID:
27005736
7.

Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements?

Ruiz-Hurtado G, Gorostidi M, Waeber B, Ruilope LM.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):488-91. doi: 10.1097/MNH.0000000000000162. Review.

PMID:
26371523
8.

Thoracic fat volume is independently associated with coronary vasomotion.

Dunet V, Feihl F, Dabiri A, Allenbach G, Waeber B, Heinzer R, Prior JO.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):280-7. doi: 10.1007/s00259-015-3160-0. Epub 2015 Aug 19.

9.

Impact of Study Design on Reported Incidences of Acute Mountain Sickness: A Systematic Review.

Waeber B, Kayser B, Dumont L, Lysakowski C, Tramèr MR, Elia N.

High Alt Med Biol. 2015 Sep;16(3):204-15. doi: 10.1089/ham.2015.0022. Epub 2015 Jul 31. Review.

PMID:
26230550
10.

Efficacy of Antihypertensive Monotherapies Assessed by Ambulatory Blood Pressure Monitoring: Is There Really a Winner?

Waeber B, Feihl F.

J Clin Hypertens (Greenwich). 2015 Nov;17(11):866-7. doi: 10.1111/jch.12625. Epub 2015 Jul 24. No abstract available.

11.

Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.

Marques-Vidal P, Waeber G, Waeber B, Vollenweider P.

J Hypertens. 2015 Apr;33(4):868-73. doi: 10.1097/HJH.0000000000000466.

PMID:
25915892
12.

Impact of body tilt on the central aortic pressure pulse.

Rotaru C, Liaudet L, Waeber B, Feihl F.

Physiol Rep. 2015 Apr;3(4). pii: e12360. doi: 10.14814/phy2.12360.

13.

Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.

Parapanov R, Lugrin J, Rosenblatt-Velin N, Feihl F, Waeber B, Milano G, Vergely C, Li N, Pacher P, Liaudet L.

Clin Sci (Lond). 2015 Jul;129(2):187-98. doi: 10.1042/CS20140444.

PMID:
25757463
14.

Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction.

Lugrin J, Parapanov R, Rosenblatt-Velin N, Rignault-Clerc S, Feihl F, Waeber B, Müller O, Vergely C, Zeller M, Tardivel A, Schneider P, Pacher P, Liaudet L.

J Immunol. 2015 Jan 15;194(2):499-503. doi: 10.4049/jimmunol.1401948. Epub 2014 Dec 10.

15.

[Hypertension and medication compliance: a challenge every day].

Vuignier Y, Burnier M, Waeber B, Wuerzner G.

Praxis (Bern 1994). 2014 Dec 10;103(25):1515-9. doi: 10.1024/1661-8157/a001867. Review. German.

PMID:
25491054
16.

Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.

Bielmann C, Rignault-Clerc S, Liaudet L, Li F, Kunieda T, Sogawa C, Zehnder T, Waeber B, Feihl F, Rosenblatt-Velin N.

Basic Res Cardiol. 2015 Jan;110(1):455. doi: 10.1007/s00395-014-0455-4. Epub 2014 Dec 2.

PMID:
25449896
17.

Can the development of severe hypertension be predicted?

Waeber B, Feihl F.

J Hypertens. 2014 Dec;32(12):2353-4. doi: 10.1097/HJH.0000000000000386. No abstract available.

PMID:
25376248
18.

Physiological response to whole-body vibration in athletes and sedentary subjects.

Gojanovic B, Feihl F, Gremion G, Waeber B.

Physiol Res. 2014;63(6):779-92. Epub 2014 Aug 26.

19.

High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?

Pradervand PA, Clerc S, Frantz J, Rotaru C, Bardy D, Waeber B, Liaudet L, Vial Y, Feihl F.

Placenta. 2014 Sep;35(9):784-6. doi: 10.1016/j.placenta.2014.06.370. Epub 2014 Jul 9.

PMID:
25043672
20.

No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus.

Vionnet J, Calero-Romero I, Heim A, Rotaru C, Engelberger RP, Dischl B, Noël B, Liaudet L, Waeber B, Feihl F.

Microcirculation. 2014 Nov;21(8):730-7. doi: 10.1111/micc.12154.

PMID:
24976374
21.

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.

J Hypertens. 2014 Jul;32(7):1359-66. doi: 10.1097/HJH.0000000000000221.

PMID:
24886823
22.

Nebivolol and valsartan: useful treatment for hypertension?

Waeber B, Feihl F.

Lancet. 2014 May 31;383(9932):1864-6. doi: 10.1016/S0140-6736(14)60836-9. No abstract available.

PMID:
24881977
23.

Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.

Wuerzner G, Muller O, Erne P, Cook S, Sudano I, Lüscher TF, Noll G, Kaufmann U, Rickli H, Waeber B, Kaiser C, Sticherling C, Pechère-Bertschi A, Baumgartner I, Jacob AL, Burnier M, Qanadli SD; Swiss Society of Hypertension; Swiss Society of Cardiology; Swiss Society of Angiology; Swiss Society of Cardiovascular and Interventional Radiology.

Swiss Med Wkly. 2014 Mar 20;144:w13913. doi: 10.4414/smw.2014.13913. Review.

24.

[Ambulatory blood pressure monitoring: essential for diagnosing and treating hypertension?].

Waeber B, Wuerzner G.

Rev Med Suisse. 2014 Jan 15;10(412-413):57-8, 60. Review. French.

PMID:
24558900
25.

A guide for easy- and difficult-to-treat hypertension.

Schmieder RE, Volpe M, Waeber B, Ruilope LM.

Int J Cardiol. 2014 Mar 1;172(1):17-22. doi: 10.1016/j.ijcard.2013.12.125. Epub 2014 Jan 4. Review.

PMID:
24456885
26.

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology.

Blood Press. 2014 Feb;23(1):3-16. doi: 10.3109/08037051.2014.868629. Epub 2013 Dec 20. No abstract available.

PMID:
24359485
27.
28.

Diagnosis and treatment of resistant hypertension.

Waeber B, Volpe M, Ruilope LM, Schmieder RE.

Blood Press. 2014 Aug;23(4):193-9. doi: 10.3109/08037051.2013.854946. Epub 2013 Nov 15.

PMID:
24229062
29.

[New recommendations of the ESH/ESC: smooth changes for the hypertensive patient].

Waeber B, Wuerzner G.

Rev Med Suisse. 2013 Sep 11;9(397):1639-42, 1644. French.

PMID:
24073476
30.

[Orthostatic hypotension: what to think of it and what to do?].

Waeber B, Pruvot E.

Rev Med Suisse. 2013 Sep 11;9(397):1618-21. French.

PMID:
24073472
31.

[Hypertension: new European guidelines have arrived! BP <140/90 mmHg for all].

Burnier M, Bertschi AP, Waeber B.

Rev Med Suisse. 2013 Sep 11;9(397):1611. French. No abstract available.

PMID:
24073470
32.

European Society of Hypertension position paper on ambulatory blood pressure monitoring.

O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring.

J Hypertens. 2013 Sep;31(9):1731-68. doi: 10.1097/HJH.0b013e328363e964. Erratum in: J Hypertens. 2013 Dec;31(12):2467.

PMID:
24029863
33.

Do optimal antihypertensive drug regimens allow blood pressure normalization in all patients with resistant hypertension?

Waeber B, Feihl F.

Hypertension. 2013 Oct;62(4):680-1. doi: 10.1161/HYPERTENSIONAHA.113.01800. Epub 2013 Aug 5. No abstract available.

PMID:
23918753
34.

Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.

Li J, Loukili N, Rosenblatt-Velin N, Pacher P, Feihl F, Waeber B, Liaudet L.

PLoS One. 2013 Jul 10;8(7):e70331. doi: 10.1371/journal.pone.0070331. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/4cf3075f-3090-44d7-aa9e-8a927ed9d5fa.

35.

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members.

J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc. No abstract available.

PMID:
23817082
36.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA.

Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14. No abstract available.

PMID:
23771844
37.

Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.

Waeber B, Feihl F.

EuroIntervention. 2013 May;9 Suppl R:R29-34. doi: 10.4244/EIJV9SRA6. Review.

PMID:
23732152
38.

Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study.

Calvo-Bonacho E, Ruilope LM, Sánchez-Chaparro MA, Cerezo C, Catalina-Romero C, Martínez-Muñoz P, Banegas JR, Waeber B, Gonzalez-Quintela A, Zanchetti A.

Eur Heart J. 2014 Feb;35(5):299-306. doi: 10.1093/eurheartj/eht156. Epub 2013 May 2.

PMID:
23641010
39.

The need for hospitalization still represents a major burden for hypertensive patients and healthcare systems.

Waeber B, Feihl F.

J Hypertens. 2013 May;31(5):880-1. doi: 10.1097/HJH.0b013e3283606b34. No abstract available.

PMID:
23552028
40.

The hemodynamics of septic shock: a historical perspective.

Feihl F, Waeber B, Liaudet L.

Curr Vasc Pharmacol. 2013 Mar 1;11(2):133-8.

PMID:
23506492
41.

[Hypertension. Effects of antihypertensive therapy on cognitive functions].

Waeber B, Feihl F.

Rev Med Suisse. 2013 Jan 16;9(369):108, 110-1. French.

PMID:
23409646
42.

Therapeutic strategies to improve control of hypertension.

Armario P, Waeber B.

J Hypertens. 2013 Mar;31 Suppl 1:S9-12. doi: 10.1097/HJH.0b013e32835d2c6c.

PMID:
23389085
43.

A community-based intervention program to effectively treat hypertension in developing countries.

Waeber B, Feihl F.

J Hypertens. 2013 Jan;31(1):47-8. doi: 10.1097/HJH.0b013e32835c7ca0. No abstract available.

PMID:
23221931
44.

Mild hypertension: to treat or not to treat?

Waeber B, Siragy HM.

Curr Hypertens Rep. 2013 Feb;15(1):1-2. doi: 10.1007/s11906-012-0317-0. No abstract available.

PMID:
23152161
45.

Pulse wave analysis of aortic pressure: diastole should also be considered.

Heim A, Liaudet L, Waeber B, Feihl F.

J Hypertens. 2013 Jan;31(1):94-102. doi: 10.1097/HJH.0b013e32835ae97d.

PMID:
23149562
46.

The past, present and future of renin-angiotensin aldosterone system inhibition.

Mentz RJ, Bakris GL, Waeber B, McMurray JJ, Gheorghiade M, Ruilope LM, Maggioni AP, Swedberg K, Piña IL, Fiuzat M, O'Connor CM, Zannad F, Pitt B.

Int J Cardiol. 2013 Sep 1;167(5):1677-87. doi: 10.1016/j.ijcard.2012.10.007. Epub 2012 Oct 31. Review.

47.

No implication of thromboxane prostanoid receptors in reactive hyperemia of skin and skeletal muscle in human forearm.

Pasche A, Heim A, Liaudet L, Waeber B, Feihl F.

J Cardiovasc Pharmacol. 2013 Feb;61(2):127-32. doi: 10.1097/FJC.0b013e3182798ad8.

PMID:
23107873
48.

Functional late outgrowth endothelial progenitors isolated from peripheral blood of burned patients.

Rignault-Clerc S, Bielmann C, Delodder F, Raffoul W, Waeber B, Liaudet L, Berger MM, Feihl F, Rosenblatt-Velin N.

Burns. 2013 Jun;39(4):694-704. doi: 10.1016/j.burns.2012.09.027. Epub 2012 Oct 25.

PMID:
23102579
49.

Plasma renin levels: the lower the better in terms of cardiovascular risk?

Waeber B, Feihl F.

Eur Heart J. 2012 Nov;33(21):2634-5. doi: 10.1093/eurheartj/ehs245. Epub 2012 Oct 4. No abstract available.

PMID:
23041500
50.

[Are all diuretics equal for the treatment of hypertensive patients?].

Waeber B, Feihl F.

Rev Med Suisse. 2012 Sep 12;8(353):1699-701. Review. French.

PMID:
23029982

Supplemental Content

Loading ...
Support Center